Please assess the completion status of the following clinical trial:

Trial Title: Autologous Conditioned Serum: Functional and Clinical Results

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* knee osteoarthritis \>3 months in clinical and radiographic signs~* VAS for pain \>50mm~Exclusion Criteria:~* Hepatitis B~* Hepatitis C~* HIV~* pregnancy~* drug abuse~* other intra-articular injections \<6 months~* surgery on affected knee \<12 months

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Autologous Conditioned Serum (Type: EXPERIMENTAL): Patients that were deemed admissible to the trial received 1 intra-articular injection of autologous conditioned serum (Orthokine®) for 4 consecutive weeks at the site of OA. These patients were then followed at 1 month and 6 months for clinical and functional evaluation using VAS for pain, WOMAC, and KSS.

Based on this trial design, predict the completion outcome and termination type (if applicable).